Clinical and Immune Impact of Mycobacterium bovis BCG Vaccination Scarring

The World Health Organization recommends Mycobacterium bovis BCG vaccination in areas of high tuberculosis prevalence. BCG's clinical and immune effects, not necessarily Mycobacterium tuberculosis specific, are unclear. BCG vaccine scarring often is used as a surrogate marker of vaccination or...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Jason, Janine, Archibald, Lennox K., Nwanyanwu, Okey C., Kazembe, Peter N., Chatt, Julie A., Norton, Elizabeth, Dobbie, Hamish, Jarvis, William R.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2002
Assuntos:
Microbial Immunity and Vaccines
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC130324/
https://ncbi.nlm.nih.gov/pubmed/12379697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.70.11.6188-6195.2002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares